I outsource the delivery and transportation of medicinal and/or health products to a third party logistic service provider (LSP). Will the LSP be accountable for issues arising from the delivery and transportation of the products to patients?
Healthcare Services (General) Regulations, Requirements on Transportation of Health Products
Where the medicinal or health products are delivered and transported by an outsourced LSP, the licensee remains accountable for any issues arising from the delivery and transportation of the products to patients.
As such, the licensee should: (a) ensure that the LSP conduct routine selfchecks/audits; and (b) conduct internal checks/audits on the LSP to ensure that the processes and risk mitigation measures put in place to ensure that delivery and transportation process are carried out in accordance with Regulation 31 of the Healthcare Services (General) Regulations 2021 and with the service level agreement between the licensee and the LSP.
Related questions
What is the expected protocol to handle a delivery error?
What are some measures that a licensee should take to ensure that the medicinal or health products are delivered or transported directly to the intended destination without any diversion or deviation from the intended route?
What are some measures that a licensee should take to ensure that the medicinal or health products are protected from any likelihood of contamination during delivery and transportation?
Whose responsibility is it if the specimen is compromised/destroyed during the transport? Is it the licensee or the outsourced transportation provider (e.g., the courier)?
Need more help?
Describe your issues to us.
